TREATMENT OF HEPATITIS C VIRUS INFECTIONS WITH TELAPREVIR (VX-950) IN PATIENTS NON-RESPONSIVE TO TREATMENT WITH PEGYLATED INTERFERON-ALPHA-2A/2B AND RIBAVIRIN

摘要

TREATMENT OF HEPATITIS C VIRUS INFECTIONS WITH TELAPREVIR (VX 950) IN PATIENTS NON-RESPONSIVE TO TREATMENT WITH PEGYLATED INTERFERON-ALPHA-2A/2B AND RIBAVIRINThe present invention relates to antiviral therapies and compositions for treating or preventing Hepatitis C infections in patients and relates to other methods10 disclosed herein. The invention also relates to kits and pharmaceutical packs comprising compositions and dosage forms. The invention also relates to processes for preparing these compositions, dosages, kits, and packs. 15 (No Suitable Figures)